MHRA Drug Safety Update September 2022
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 2 September 2022) has been published and includes articles on: Methylphenidate long-acting (modified-release) preparations: caution if switching between products due to differences in formulations Rucaparib (Rubraca▼): withdrawal of third-line treatment indication COVID-19 vaccines and medicines: updates for September 2022 Letters [...]
The post MHRA Drug Safety Update September 2022 appeared first on PSNC Website.
Recent Comments